House Subpoenas FDA Staffers In Ketek Investigation
Von Eschenbach’s congressional briefing documents also subpoenaed as panel delves into when FDA and Sanofi-Aventis became aware of flawed safety study.
Von Eschenbach’s congressional briefing documents also subpoenaed as panel delves into when FDA and Sanofi-Aventis became aware of flawed safety study.